NDC properties for "adalimumab-aaty 40 MG per 0.4 ML Prefilled Syringe" (RxCUI 2639659)
About this data
The tables show NDC propoerties for adalimumab-aaty 40 MG per 0.4 ML Prefilled Syringe with the RxCUI 2639659
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-aaty 40 MG per 0.4 ML Prefilled Syringe (RxCUI 2639659)
| BLA | BLA761219 |
|---|---|
| MMSL_CODE | MTH_RXN_BD39482 |
| RxCUI | 2639659 |
| SPL_SET_ID | c44365e9-d470-4e35-978d-8565a9e3471e |
| VUID | 4042487 |
| Prescribable Synonym | adalimumab-aaty 40 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | 0.4 ML adalimumab-aaty 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-aaty 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | adalimumab-aaty 40 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2639659) |
NDC Properties
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002201
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-01 |
| NDC Item | 72606002201 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002202
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-02 |
| NDC Item | 72606002202 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002203
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-03 |
| NDC Item | 72606002203 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002204
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-04 |
| NDC Item | 72606002204 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002205
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-05 |
| NDC Item | 72606002205 |
| Packaging | 1 SYRINGE in 1 CARTON (72606-022-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002206
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-06 |
| NDC Item | 72606002206 |
| Packaging | 2 SYRINGE in 1 CARTON (72606-022-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002207
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-07 |
| NDC Item | 72606002207 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-022-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |
NDC Item 72606002208
| NDC 9 | 72606-022 |
|---|---|
| NDC 10 | 72606-022-08 |
| NDC Item | 72606002208 |
| Packaging | 6 SYRINGE in 1 CARTON (72606-022-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-022 |